{"id":"NCT00162942","sponsor":"Otsuka America Pharmaceutical","briefTitle":"Study for the Treatment of Crohn's Disease With Adacolumn","officialTitle":"A Randomized, Prospective, Double-Blinded, Placebo-Controlled (Sham-Controlled) Study to Evaluate the Safety and Effectiveness of the Adacolumn Apheresis System for the Treatment of Moderate to Severe Crohn's Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-01","primaryCompletion":"2007-12","completion":"2007-12","firstPosted":"2005-09-13","resultsPosted":"2009-04-07","lastUpdate":"2009-04-07"},"enrollment":235,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Crohn's Disease"],"interventions":[{"type":"DEVICE","name":"Adacolumn","otherNames":[]},{"type":"DEVICE","name":"Sham","otherNames":[]}],"arms":[{"label":"Adacolumn","type":"ACTIVE_COMPARATOR"},{"label":"Sham","type":"SHAM_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the safety and effectiveness of the Adacolumn Apheresis System as a treatment for the signs and symptoms of Crohn's disease.","primaryOutcome":{"measure":"Clinical Remission","timeFrame":"Baseline to Week 12","effectByArm":[{"arm":"Adacolumn","deltaMin":17.8,"sd":null},{"arm":"Sham","deltaMin":19.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":".858"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":21},"locations":{"siteCount":37,"countries":["United States","Canada"]},"refs":{"pmids":["22760005"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":null,"commonTop":[]}}